Month: May 2020

Trésorerie, équivalents de trésorerie et actifs financiers s’élevant à 206,9 millions d’eurosiPremier patient traité dans l’essai de Phase II évaluant avdoralimab (anti-C5aR) chez des patients atteints d’une pneumonie sévère due au COVID-19Premier patient traité dans l’essai de Phase I évaluant IPH5201 chez des patients atteints de tumeurs solides avancéesDe nouvelles données d’efficacité issues de l’essai de Phase Ib/II évaluant la combinaison de monalizumab et cetuximab chez des patients présentant un cancer de la tête et du cou ayant déjà été traités par immunothérapie seront présentées à l’ ASCO20 Virtual Scientific Program         Innate Pharma SA (la « Société » – Euronext Paris : FR0010331421 – IPH ; Nasdaq : IPHA) annonce aujourd’hui son chiffre d’affaires et sa position de trésorerie pour les trois premiers...

Neurocrine Biosciences to develop and commercialize ACT-709478, a clinical stage selective T-type calcium channel blocker for the treatment of a rare pediatric epilepsy – Phase 2 study planned for the second half of 2020.Idorsia receives a $45 million upfront payment in cash.Idorsia will also be entitled to potential development and regulatory milestone payments up to $365 million and tiered royalties on net sales.SAN DIEGO, US and ALLSCHWIL, Switzerland – May 12, 2020Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Idorsia Ltd (SIX: IDIA) today announced that following Investigational New Drug (IND) application acceptance by the US Food and Drug Administration (FDA), Neurocrine Biosciences has exercised its option to license the global rights to Idorsia’s ACT-709478. Neurocrine Biosciences plans to initiate a Phase 2 study with this potent,...

Neurocrine Biosciences to develop and commercialize ACT-709478, a clinical stage selective T-type calcium channel blocker for the treatment of a rare pediatric epilepsy – Phase 2 study planned for the second half of 2020.Idorsia receives a $45 million upfront payment in cash.Idorsia will also be entitled to potential development and regulatory milestone payments up to $365 million and tiered royalties on net sales.SAN DIEGO, US and ALLSCHWIL, Switzerland – May 12, 2020Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Idorsia Ltd (SIX: IDIA) today announced that following Investigational New Drug (IND) application acceptance by the US Food and Drug Administration (FDA), Neurocrine Biosciences has exercised its option to license the global rights to Idorsia’s ACT-709478. Neurocrine Biosciences plans to initiate a Phase 2 study with this potent,...

EEZY PLC  —  COMPANY ANNOUNCEMENT  —  12 MAY 2020 AT 8:00Eezy Plc’s Interim Report 1-3/2020: Adapting to Corona crisis has started well  January–March 2020Revenue was EUR 55.1 million (EUR 28.4 million in January-March 2019). Revenue increased by 94,3%.EBITDA was EUR 2.8 million (2.8), decreased by 0.4%EBIT was EUR 1.0 million (2.1), decreased by 53.0%.Adjusted EBITDA was EUR 2.8 million (2.9), decreased by 3.6%.Adjusted EBIT was EUR 1.0 million (2.2), decreased by 55.7%.Earnings per share was EUR 0.02 (0.08).Corona crisis has affected the business negatively.Outlook for 2020Eezy has on 20 March 2020 cancelled the earlier guidance for year 2020 due to the corona crisis and has not set a new guidance for year 2020. A new guidance will be provided when the company has a better understanding of the duration and effects...

In April 2020, AS LHV Group earned EUR 1.6 million in net loss. The loss of AS LHV Pank made up EUR 2.1 million of it and AS LHV Varahaldus earned EUR 0.5 million in net profit.The April results were influenced to a large extent by the deteriorating economic situation resulting from the emergency situation, as the bank increased the loan impairment reserve and the impairment loss amounted to EUR 5.6 million largely due to a more negative outlook of the macro-economy. These are model-based impairments, insofar as the actual credit portfolio has remained strong. The share of debts in the corporate loan portfolio, overdue for more than 30 days, was 0.3% as at the end of April. Whereas the actual amount of allowances was EUR 1.2 million less than in the financial plan published in April.Business volumes continued to grow, as the deposit volume...

EEZY OYJ  —  YHTIÖTIEDOTE  —  12.5.2020 KLO 8.00Eezy Oyj:n osavuosikatsaus 1-3/2020: Koronakriisiin sopeutuminen alkanut hyvinTammi–maaliskuu 2019Liikevaihto oli 55,1 milj. euroa (28,4 milj. euroa tammi–maaliskuussa 2019). Liikevaihto kasvoi 94,3 %.Käyttökate oli 2,8 milj. euroa (2,8), laskua 0,4 %.Liikevoitto oli 1,0 milj. euroa (2,1), laskua 53,0 %.Oikaistu käyttökate oli 2,8 milj. euroa (2,9), laskua 3,6 %.Oikaistu liikevoitto oli 1,0 milj. euroa (2,2), laskua 55,7 %.Osakekohtainen tulos oli 0,02 euroa (0,08) osakkeelta.Koronakriisi on vaikuttanut liiketoimintaan negatiivisesti.            Näkymät vuodelle 2020Eezy on 20.3.2020 päättänyt luopua aiemmin julkistetusta tulosennusteesta koronakriisin takia eikä ole määrittänyt uutta tulosennustetta vuodelle 2020. Tulosennuste annetaan, kun yhtiöllä on paremmat edellytykset...

VANCOUVER, British Columbia, May 12, 2020 (GLOBE NEWSWIRE) — Bolt Metals Corp. (CSE: BOLT) (FRANKFURT: NXFE) (OTCQB: PCRCF) (the “Company” or “Bolt Metals”) is pleased to announce that the Cyclops Project License is now registered in the database of the Directorate General of Minerals and Coal, Ministry of Energy and Mineral Resources of the Republic of Indonesia with related physical documentation expected shortly.In spite of COVID-19 related challenges, the Cyclops project site is secure with no known cases in the direct project area. The Jakarta head office and the Sentani site camp and logistics base are operating at reduced levels and field activities will recommence once the nationwide lockdown is lifted.The Company will continue to monitor the situation and act within the guidelines and recommendations of the provincial,...

KAPALUA RESORT, Hawaii, May 11, 2020 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (“MLP”) (NYSE: MLP) today announced that major repairs of the West Maui ditch system to restore the damage caused by Hurricanes Lane and Olivia have been completed.The water from the ditch is used by the County of Maui Water Treatment Facility, Kapalua Water Company, Ltd., and various residents and farmers for drinking, irrigation, and fire suppression. The damage caused by the hurricanes resulted in irregular and inconsistent water availability due to the extensive flooding which reduced the flows and damaged a critical control gate.As part of the restoration process, a full assessment of the ditch system was completed by MLP’s engineers and contractors prior to commencing the repair effort in December 2019. The first phase of the repair...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY IN OR INTO CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAWThis announcement is for distribution only to persons who (a) have professional experience in matters relating to investments falling within Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”); (b) are persons falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations, etc.”) of the Order; (c) are outside the United Kingdom (“UK”); or (d) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities...

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused on single-tenant industrial real estate investments, today announced that it has priced its underwritten public offering of 15,000,000 common shares at a per share public offering price of $9.60 for expected gross proceeds of the offering of approximately $144.0 million before deducting underwriting discounts and commissions and estimated offering expenses. As part of the offering, Lexington has also granted the underwriters a 30-day option to purchase up to an additional 2,250,000 common shares.The offering is subject to customary closing conditions and is expected to close on May 14, 2020.Lexington intends to use the net proceeds from the offering for working capital and general corporate purposes,...